-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615.P1.59 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster I

Symposia: Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Jun Li1*, Yanqing Huang1*, Yue Hou1*, Jie Zi1*, Chunhua Song, MD,PhD2,3 and Zheng Ge, MD, PhD1

1Department of Hematology, Zhongda Hospital, School of Medicine, Institute of Hematology, Southeast University, Nanjing, China
2Hershey Medical Center, Pennsylvania State University Medical College, Hershey
3Division of Hematology, The Ohio State University Wexner Medical Center, the James Cancer Hospital, Columbus

Jonathan A. Gutman, MD1, Amanda C. Winters, MD, PhD2, Andrew Kent, MD, PhD3*, Maria L. Amaya, MD, PhD4, Christine M. McMahon, MD4, Clayton Smith, MD5*, Craig T Jordan, PhD6, Brett M. Stevens, PhD4, Mohammad Minhajuddin, PhD4*, Shanshan Pei, PhD7*, Jeffrey Schowinsky, MD6*, Jennifer Tobin, PharmD8*, Kelly O'Brien, NP5*, Angela Falco, NP9*, Elizabeth Taylor, RN9*, Constance Brecl, BA, CCRP, RAC9*, Phuong Ho, BS10*, Connor Sohalski, BS9*, Jessica Dell-Martin, BS9*, Olivia Ondracek, BS11*, Diana Abbott, PhD12* and Daniel A. Pollyea, MD13

1Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO
2University of Colorado Anschutz Medical Campus, Aurora, CO
3Department of Medicine, University of Colorado Hospital, Denver, CO
4Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
5Division of Hematology, University of Colorado, Aurora, CO
6University of Colorado, Aurora, CO
7University of Colorado, Anschutz Medical Campus, Aurora, CO
8University of Colorado Cancer Center, Aurora, CO
9Division of Hematology, University of Colorado, Aurora
10University of Colorado, Aurora
11Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical School, Aurora, CO
12Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Denver, CO
13Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Denver, CO

Farhad Ravandi, MD1, Pau Montesinos, MD, PhD2*, Michael Pfeilstöcker, MD3*, Cristina Papayannidis, MD, PhD4, Hervé Dombret, MD, PhD5,6, Yinzhi Lai, PhD7*, Erica Petrlik, MD, MPH7*, Thomas Prebet, MD, PhD7* and Hartmut Döhner, MD8

1The University of Texas MD Anderson Cancer Center, Houston, TX
2Hospital Universitario y Politécnico La Fe, Valencia, Spain
3Hanusch Hospital, Vienna, Austria
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
5Institut de Recherche Saint Louis, Université de Paris, Paris, France
6Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, France
7Bristol Myers Squibb, Princeton, NJ
8Ulm University Hospital, Ulm, Germany

Tara L. Lin, MD1, Praneeth Baratam2*, Robert K. Stuart2*, Roland B. Walter, MD, PhD, MS3, Eric S. Winer, MD4, Stefan Faderl5*, Vijayalakshmi Chandrasekaran6*, Divya Chakravarthy5*, Ronald S. Cheung5 and Vinod A. Pullarkat, MD7*

1University of Kansas Medical Center, Kansas City, KS
2Medical University of South Carolina, Charleston, SC
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Jazz Pharmaceuticals, Palo Alto, CA
6Jazz Pharmaceuticals, Philadelphia, PA
7Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Amer M. Zeidan, MD1, Wei-Han Cheng, PhD2*, Rajesh Kamalakar, MS2*, Catherine Miller, PharmD2*, Cat N. Bui, PharmD2*, Melissa Montez, PharmD3*, Tracy Yee, PhD, MPH4*, Zheng Wu, MS4* and Scott F. Huntington, MD, MPH1

1Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
2AbbVie, Inc, Health Economics and Outcomes Research - Oncology, Chicago, IL
3Genentech, Inc, Health Economics and Outcomes Research - Oncology, San Francisco, CA
4Genesis Research, LLC, Hoboken, NJ

Amir T. Fathi, MD1, Geoffrey G Fell2*, Areej El-Jawahri, MD3,4*, Alexander E. Perl, MD5, Brian A. Jonas, MD, PhD6, Ajoy L. Dias, MD7, Alice S. Mims, MD8, Uma Borate, MD9, Brittany Knick Ragon, MD10, Michael R. Grunwald, MD11, Mary Linton B. Peters, MD12*, Timothy A. Graubert, MD13, Philip C. Amrein, MD14, Hanno R. Hock, MD, PhD15*, Andrew M. Brunner, MD16, Gabriela S. Hobbs, MD17, Rupa Narayan, MD18, Donna S. Neuberg, ScD2 and Ibrahim Aldoss, MD19

1Massachusetts General Hospital, Harvard Medical School, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Massachusetts General Hospital/Harvard Medical School, Boston, MA
4Blood and Marrow Transplant Program, Massachusetts General Hospital, Allston, MA
5University of Pennsylvania, Philadelphia, PA
6Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
7Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
8Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
9Division of Hematology, The Ohio State University, Columbus, OH
10Levine Cancer Institute, Atrium Health, Charlotte, NC
11Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
12Beth Israel Deaconess Medical Center, Boston, MA
13Massachusetts General Hospital Cancer Center, Charlestown, MA
14Leukemia Center/MGH Cancer Center, Massachusetts General Hospital, Belmont, MA
15Leukemia Center, Massachusetts General Hospital / Harvard Medical School, Boston, MA
16Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
17Cancer Center, Massachusetts General Hospital, Boston, MA
18Massachusetts General Hospital Cancer Center, Boston, MA
19City of Hope, Duarte, CA

Man Wai Tang, PhD1, Deborah van der Tuin1*, Mesire Aydin1*, Jarom Heijmans, MD, PhD1*, Arjan A. van de Loosdrecht, MD, PhD2*, Ellen Meijer, MD, PhD1, Caroline E. Rutten, MD, PhD1*, Marielle Wondergem, MD, PhD1, Jeroen J.W.M. Janssen, MD, PhD1*, Marjolein Donker, MD, PhD1*, Mette D. Hazenberg, MD, PhD3*, Sonja Zweegman, MD, PhD4, Bart J Biemond5, David C. de Leeuw, MD, PhD1* and Erfan Nur, MD, PhD1

1Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands
2Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Department of Hematology, Amsterdam UMC Cancer Center Amsterdam, Amsterdam, Netherlands
4Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands
5Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands

Toshiki Terao, MD*, Ken-ichi Matsuoka, MD, PhD, Hiroko Ueda, MD*, Akifumi Matsumura, MD*, Chisato Matsubara, MD*, Kaho Kondo, MD*, Takumi Kondo, MD, PhD*, Hideaki Fujiwara, MD, PhD, Noboru Asada, MD, PhD, Daisuke Ennishi, MD, PhD, Hisakazu Nishimori, MD, PhD*, Keiko Fujii, MD, PhD*, Nobuharu Fujii, MD, PhD* and Yoshinobu Maeda, MD, PhD

Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan

Jie Zha, MD, PhD1*, Hui Zhou1*, Mengya Zhong, MD, PhD1,2*, Ying Wang, MD3, Xin Du4*, Tiejun Gong5*, Zhijuan Lin, MD6*, Yun Cai7*, Siting Xie6*, Chendi Xie6*, XianQi Feng8*, ZhenQi Huang9*, Liping Su10*, Jianmin Luo11*, Lin Yang12*, Zhenling Li13*, Bi-yun Chen, MD, PhD14*, Ying Xie15*, Yu Zhu, MD, PhD16*, Pengcheng Shi17*, Zhifeng Li18*, Yirong Jiang19* and Bing Xu, MD, PhD20*

1Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
2Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, xiamen, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, CA, China
5Harbin Institute of Hematology and Oncology, Harbin First Hospital,150010 Harbin,Heilongjiang,China, Harbin, China
6Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, xiamen, China
7Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, shenzhen, China
8Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
9The First Affiliated Hospital of Anhui Medical University, Hefei, China
10Department of Hematology, Shanxi Cancer Hospital, Taiyuan, China
11The Second Hospital of Hebei Medical University, Shijiazhuang, China
12Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, CHN
13Department of Hematology, China-Japan Friendship Hospital, Beijing, China
14Department of Hematology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China
15Department of Hematology, Fujian Provincial Hospital, Fuzhou, China
16Department of Hematology, Collaborative Innovation Center for Cancer Personalized Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial People’s Hospital, Nanjing, China
17Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
18Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, China
19Department of Hematology, Dongguan People’s Hospital, Dongguan, China
20Department of Hematology, The first Affiliated Hosptial of Xiamen University, Xiamen, China

Vishesh Khanna, MD1, Tali Azenkot, MD2*, Selina (Qiuying) Liu, MD3, Jason Gilbert, MD4*, Edna Cheung, PharmD5*, Kimberly Lau, PharmD5*, Daniel A. Pollyea, MD4, Elie Traer, MD, PhD3, Brian A. Jonas, MD, PhD6, Tian Y. Zhang5 and Gabriel N. Mannis, MD7

1Division of Hematology, Department of Medicine, Stanford University Medical Center, Palo Alto, CA
2Department of Internal Medicine, University of California Davis School of Medicine, Sacramento
3Knight Cancer Institute, Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR
4Division of Hematology, University of Colorado School of Medicine, Aurora, CO
5Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA
6Division of Cellular Therapy, Bone Marrow Transplant, and Malignant Hematology, Department of Medicine, University of California Davis School of Medicine, Sacramento, CA
7Division of Hematology, Department of Medicine, Stanford University Medical Center, Menlo Park, CA

Hannah Otiker, PharmD1*, Gustavo Rivero, MD2, Ashley Sidebottom1* and Grace Hwang, PharmD1*

1Department of Pharmacy, Baylor St.Luke's Medical Center, Houston, TX
2Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX

Xiaohong Liu1*, Yao Li1*, Wenjing Yu, MD1*, Xiaolu Zhu1*, Jinsong Jia1*, Lizhong Gong1*, Xiaosu Zhao1*, Yingjun Chang1*, Xiao-Jun Huang1 and Hao Jiang2*

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China

Sai Prasad Desikan, MD1*, Hagop Kantarjian, MD2, Elias Jabbour, MD1, Kelly S. Chien, MD1, Guillermo Montalban-Bravo, MD1, Yesid Alvarado, MD1, Gautam Borthakur, MD1, Ghayas C. Issa, MD3, Naval Daver, MD1, Naveen Pemmaraju, MD1, Musa Yilmaz, MD4, Danielle Hammond, MD1, Abhishek Maiti, MBBS5, Courtney D. DiNardo, MD, MSCE1, Farhad Ravandi, MD1, Guillermo Garcia-Manero, MD6 and Tapan M. Kadia, MD4

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Andree-Anne Pelland, MD, Xavier Savard, MD*, Frederic Barabe, MD, Vincent Laroche, MD, Michaël Munger, MD*, Genevieve Gallagher, MD, Nicolas Marcoux, MD, Guy Cantin, MD*, Maxime Chénard-Poirier, MD*, Robert Delage, MD, Marc Lalancette, MD and Christopher Lemieux, MD

Centre intégré de cancérologie, CHU de Québec - Université Laval, Quebec, QC, Canada

Ellen Madarang, PharmD1*, Jillian Lykon, PharmD1*, Wei Zhao, MD, MS2*, Mikkael A. Sekeres, MD1, Terrence Bradley, MD1, Namrata Sonia Chandhok, MD1, Justin Taylor, MD1, Tulay Koru-Sengul, PhD3*, Sunil G. Iyer, MD1*, Jacopo Nanni, MD4*, Cristina Papayannidis, MD, PhD5, Ryan M Miller, PhamD6*, Ashwin Kishtagari, MBBS7, Michael R. Savona, MD8, Jason Gilbert, MD9*, Daniel A. Pollyea, MD10, David A. Sallman, MD11, Najla Al Ali, MS11, Rami S. Komrokji, MD12 and Justin Watts, MD1

1University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
2Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
3Division of Biostatistics, Department of Public Health Sciences, University of Miami, Miami, FL
4Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
5IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
6Vanderbilt Ingram Cancer Center, Nashville, TN
7Division of Hematology & Oncology, Vanderbilt Ingram Cancer Center, Franklin, TN
8Vanderbilt University School of Medicine, Nashville, TN
9Division of Hematology, University of Colorado School of Medicine, Aurora, CO
10Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Denver, CO
11Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
12Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Philip C. Amrein, MD1,2, Eyal C. Attar, MD3, Geoffrey G Fell4*, Traci M. Blonquist, MS5*, Andrew M. Brunner, MD6,7, Gabriela S. Hobbs, MD8, Hanno R. Hock, MD, PhD9*, Steven McAfee2*, Rupa Narayan, MD10,11, Jenna A. Moran, NP8*, Meghan Bergeron, NP10*, Julia E. Foster, NP10*, Christina Bertoli, NP2,10*, Kristin McGregor10*, Meghan Burke10*, Tanya T. Behnan, BS10*, Tina T. Som, RN10*, Aura Y. Ramos, RN10*, Megan K. Vartanian, RN10*, Jennifer Lombardi Story10,12*, Donna S. Neuberg, ScD4 and Amir T. Fathi, MD11,13

1Leukemia Center/MGH Cancer Center, Massachusetts General Hospital, Belmont, MA
2Massachusetts General Hospital, Boston, MA
3Aprea Therapeutics, Boston, MA
4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
5Data Science, Dana-Farber Cancer Institute, Boston, MA
6Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
7Dana-Farber Cancer Institute, Boston, MA
8Cancer Center, Massachusetts General Hospital, Boston, MA
9Leukemia Center, Massachusetts General Hospital / Harvard Medical School, Boston, MA
10Leukemia Center, Massachusetts General Hospital, Boston, MA
11Massachusetts General Hospital Cancer Center, Boston, MA
12Leukemia Program, Massachusetts General Hospital, Boston, MA
13Center for Leukemia, Massachusetts General Hospital / Harvard Medical School, Cambridge, MA

James McCloskey, MD1*, Vinod A. Pullarkat, MD2*, Gabriel N. Mannis, MD3, Tara L. Lin, MD4, Stephen A Strickland, MD, MSCI5, Amir T. Fathi, MD6, Stefan Faderl7*, Divya Chakravarthy7*, Yana Lutska8*, Vijayalakshmi Chandrasekaran8*, Ronald S. Cheung7 and Mark J. Levis, MD9

1John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
2Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
3Stanford University Medical Center, Palo Alto, CA
4University of Kansas Medical Center, Kansas City, KS
5Vanderbilt-Ingram Cancer Center, Nashville, TN
6Massachusetts General Hospital, Harvard Medical School, Boston, MA
7Jazz Pharmaceuticals, Palo Alto, CA
8Jazz Pharmaceuticals, Philadelphia, PA
9Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Rabia Shahswar, MD1*, Gernot Beutel, MD1*, Razif Gabdoulline, PhD1*, Adrian Schwarzer, MD, PhD1, Arnold Kloos, PhD1*, Christian Koenecke, MD1*, Michael Stadler, MD1*, Gudrun Göhring, MD2*, Brigitte Schlegelberger, MD2, Zhixiong Li, MD1, Louisa-Kristin Dallmann1*, Clara Wienecke1*, Piroska Klement, MD1*, Catherin Albert1*, Martin Wichmann1*, Yasmine Alwie1*, Axel Benner3*, Maral Saadati, PhD4*, Arnold Ganser, MD5*, Felicitas R. Thol, MD1 and Michael Heuser, MD1

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Department of Human Genetics, Hannover Medical School, Hannover, Germany
3Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany
4Saadati Solutions, Ladenburg, Germany
5Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany

Julia M. Unglaub, MD1*, Richard F. Schlenk, MD2,3, Maher Hanoun, MD, PhD4*, H. Christian Reinhardt, MD5*, Jan Moritz Middeke, MD6*, Kerstin Schäfer-Eckart7*, Björn Steffen, MD8*, Stefan W. Krause, MD9*, Christoph Schliemann, MD10*, Martin Kaufmann, MD11, Mathias Haenel, MD12*, Edgar Jost13*, Martina Crysandt, MD13*, Lars Fransecky, MD14*, Hermann Einsele, MD15, Sabrina Kraus16*, Dirk Niemann, MD17*, Andreas Neubauer, MD18, Ruth Seggewiss-Bernhardt, MD19*, Sebastian Scholl, MD20*, Stefan Klein, MD21, Christoph Schmid, MD22*, Markus Schaich, MD23*, Uwe Platzbecker, MD24*, Claudia D. Baldus, MD25*, Martin Bornhaeuser, MD26, Hubert Serve, MD27, Christoph Röllig, MD, MSc28*, Michael Kramer, MSc26*, Elena Katelari29*, Maike Janssen, MD3*, Caroline Pabst, MD30*, Thomas Luft, MD, PhD31, Peter Dreger, MD32, Carsten Müller-Tidow, MD33* and Tim Sauer, MD34*

1University Hospital Heidelberg, Heidelberg, Germany
2National Center of Tumor Diseases, Heidelberg, Heidelberg, Germany
3Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
4Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
5Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
6Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
7Department of Internal Medicine 5, Hospital Nürnberg, Nürnberg, Germany
8Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe-University, Frankfurt, Germany
9Department of Hematology and Medical Oncology, University Hospital Erlangen, Erlangen, Germany
10Department of Medicine A, University Hospital Münster, Münster, Germany
112nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital, Stuttgart, Germany
12Department of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany
13Department of Internal Medicine IV, University Hospital RWTH Aachen, Aachen, Germany
14Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
15Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
16University Hospital of Wurzburg, Wurzburg, DEU
17Department of Hematology/Oncology and Palliative Medicine, Ev. Stift St. Martin, Koblenz, Germany
18Hematology, Oncology, Immunology, Philipps University, Marburg, Germany
19Department of Hematology/Oncology, Sozial-Stiftung Bamberg, Bamberg, Germany
20Department of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany
21Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
22Department of Haematology and Oncology, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
23Department of Hematology, Oncology and Palliative Care, Rems-Murr-Klinikum Winnenden, Germany, Winnenden, Germany
24Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
25Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany
26Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
27Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Frankfurt, Germany
28Department of Internal Medicine I, University Hospital, Dresden, Germany
29Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
30Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
31Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
32Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany
33Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
34Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany

Gina Keiffer, MD1, Guneet Kaleka2*, Caspian Oliai, MD, MS3, Lindsay Wilde, MD1, Neil Palmisiano, MD, MS4 and Margaret Kasner, MD1

1Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
2Department of Medicine, UCLA-Olive View Medical Center, Newbury Park, CA
3UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
4Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA

*signifies non-member of ASH